SNY
Sanofi
NASDAQ · Healthcare · Drug Manufacturers - General · FR
$44.13
−0.45%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
16.2x
EV/EBITDA
8.7x
Market Cap
$105.74B
MomentumView details →
1D Return
−0.45%
YTD Return
−8.88%
RSI (14)
47.3
ValuationView details →
P/E (Fwd)
16.2x
EV/EBITDA
8.7x
Market Cap
$105.74B
RSI (14)
47.3
MomentumView details →
1D Return
−0.45%
YTD Return
−8.88%
SummaryUpdated Jun 1, 2026
Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company founded in 1973 and headquartered in Paris, France. Originally known as Sanofi-Aventis until 2011, the company has evolved into one of the world's largest pharmaceutical companies through strategic acquisitions and organic growth. Sanofi operates as a diversified healthcare company with a focus on innovative medicines, vaccines, and consumer health products, serving patients across more than 170 countries worldwide.
Similar companies
Latest newsMore news →
Sanofi will lay off 229 workers in Massachusetts, affecting employees of Blueprint Medicines, which Sanofi acquired in a $9.1 billion deal in July 2025.18d agoSanofi alerted patient groups and physicians in the U.S. and Europe that supplies of Myozyme and Nexviazyme are dwindling due to a bottleneck in the final manufacturing phase and quality control issues at its Waterford plant.26d agoSanofi announced an evolution of its Executive Committee to support its next strategic chapter.45d ago